Patents by Inventor Duk Soon HWANG

Duk Soon HWANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide that supresses binding of beta-amyloid and rage
    Patent number: 10544190
    Abstract: The present invention provides a peptide consisting of the amino acid sequence of SEQ ID NO:1 or the amino acid sequence of SEQ ID NO:2, or a pharmaceutically acceptable salt thereof and a use thereof. The present invention can inhibit the entry of beta-amyloid into the brain. In addition, the present invention can be applied more easily with respect to the suppression of the intracerebral action of beta-amyloid and thus is advantageous in having excellent applicability.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: January 28, 2020
    Assignee: ENSOL BIOSCIENCES INC.
    Inventors: Hae Jin Kim, Eun Joung Moon, Duk Soon Hwang
  • NOVEL PEPTIDE AND USE THEREOF
    Publication number: 20190161517
    Abstract: The present invention provides a peptide consisting of the amino acid sequence of SEQ ID NO:1 or the amino acid sequence of SEQ ID NO:2, or a pharmaceutically acceptable salt thereof and a use thereof. The present invention can inhibit the entry of beta-amyloid into the brain. In addition, the present invention can be applied more easily with respect to the suppression of the intracerebral action of beta-amyloid and thus is advantageous in having excellent applicability.
    Type: Application
    Filed: March 24, 2017
    Publication date: May 30, 2019
    Inventors: Hae Jin KIM, Eun Joung MOON, Duk Soon HWANG
  • Anti-cancer peptide and use thereof
    Patent number: 10189875
    Abstract: Provided are a peptide consisting of the amino acid sequence of SEQ ID NO:1 or a pharmaceutically acceptable salt thereof, and the use thereof. Cancer can be effectively prevented or treated by application of the peptide.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: January 29, 2019
    Assignee: ENSOL BIOSCIENCES INC.
    Inventors: Hae Jin Kim, Duk Soon Hwang, Eun Joung Moon
  • Anti-cancer peptide and use thereof
    Patent number: 10167316
    Abstract: Provided are a peptide consisting of the amino acid sequence of SEQ ID NO:1 or a pharmaceutically acceptable salt thereof, and the use thereof. Cancer can be effectively prevented or treated by application of the peptide.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: January 1, 2019
    Assignee: ENSOL BIOSCIENCES INC.
    Inventors: Hae JIn Kim, Duk Soon Hwang, Eun Joung Moon
  • NOVEL PEPTIDE AND USE THEREOF
    Publication number: 20180186834
    Abstract: This invention relates to a peptide consisting of an amino acid sequence of SEQ ID NO:1 or a pharmaceutically acceptable salt thereof, and to the use thereof. According to this invention, cancer can be effectively prevented or treated.
    Type: Application
    Filed: July 22, 2016
    Publication date: July 5, 2018
    Inventors: Hae Jin KIM, Duk Soon HWANG, Eun Joung MOON